| Product Code: ETC9942992 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Drug-eluting Stents Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Drug-eluting Stents Market - Industry Life Cycle |
3.4 United Kingdom (UK) Drug-eluting Stents Market - Porter's Five Forces |
3.5 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.7 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume Share, By Generation, 2021 & 2031F |
3.8 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume Share, By Scaffold, 2021 & 2031F |
3.9 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Drug-eluting Stents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in the UK |
4.2.2 Technological advancements in drug-eluting stents leading to better patient outcomes |
4.2.3 Rising demand for minimally invasive procedures in cardiology |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of drug-eluting stents |
4.3.2 High cost associated with drug-eluting stents impacting adoption rates |
4.3.3 Competition from alternative treatment options such as bare-metal stents |
5 United Kingdom (UK) Drug-eluting Stents Market Trends |
6 United Kingdom (UK) Drug-eluting Stents Market, By Types |
6.1 United Kingdom (UK) Drug-eluting Stents Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Polymer-based, 2021- 2031F |
6.1.4 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Polymer-free, 2021- 2031F |
6.2 United Kingdom (UK) Drug-eluting Stents Market, By Drug |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Sirolimus, 2021- 2031F |
6.2.3 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Paclitaxel, 2021- 2031F |
6.2.4 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Zotarolimus, 2021- 2031F |
6.2.5 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Everolimus, 2021- 2031F |
6.2.6 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Biolimus, 2021- 2031F |
6.2.7 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Drug-eluting Stents Market, By Generation |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By 1st Generation, 2021- 2031F |
6.3.3 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By 2nd Generation, 2021- 2031F |
6.3.4 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By 3rd Generation, 2021- 2031F |
6.3.5 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By 4th Generation, 2021- 2031F |
6.4 United Kingdom (UK) Drug-eluting Stents Market, By Scaffold |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Cobalt-Chromium, 2021- 2031F |
6.4.3 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Platinum-Chromium, 2021- 2031F |
6.4.4 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Nitinol, 2021- 2031F |
6.4.5 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Biodegradable, 2021- 2031F |
6.4.6 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Kingdom (UK) Drug-eluting Stents Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Coronary Diseases, 2021- 2031F |
6.5.3 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Peripheral Vascular Diseases, 2021- 2031F |
6.6 United Kingdom (UK) Drug-eluting Stents Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 United Kingdom (UK) Drug-eluting Stents Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
7 United Kingdom (UK) Drug-eluting Stents Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Drug-eluting Stents Market Export to Major Countries |
7.2 United Kingdom (UK) Drug-eluting Stents Market Imports from Major Countries |
8 United Kingdom (UK) Drug-eluting Stents Market Key Performance Indicators |
8.1 Average procedure time for implanting drug-eluting stents |
8.2 Number of clinical trials assessing the efficacy of new drug-eluting stents |
8.3 Patient satisfaction rates post drug-eluting stent implantation |
9 United Kingdom (UK) Drug-eluting Stents Market - Opportunity Assessment |
9.1 United Kingdom (UK) Drug-eluting Stents Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Kingdom (UK) Drug-eluting Stents Market Opportunity Assessment, By Drug, 2021 & 2031F |
9.3 United Kingdom (UK) Drug-eluting Stents Market Opportunity Assessment, By Generation, 2021 & 2031F |
9.4 United Kingdom (UK) Drug-eluting Stents Market Opportunity Assessment, By Scaffold, 2021 & 2031F |
9.5 United Kingdom (UK) Drug-eluting Stents Market Opportunity Assessment, By Application, 2021 & 2031F |
9.6 United Kingdom (UK) Drug-eluting Stents Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Drug-eluting Stents Market - Competitive Landscape |
10.1 United Kingdom (UK) Drug-eluting Stents Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Drug-eluting Stents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here